Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02419131 · ClinicalTrials.gov registry record · NA
Cognitive-Behavior Therapy for Posttraumatic Headache
A NA study of PTSD and Post-Traumatic Headache, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- NA
- Development phase
- 193
- Enrollment target
- 1
- Study location
NCT02419131: Completed NA study of PTSD and Post-Traumatic Headache, sponsored by The University of Texas Health Science Center at San Antonio.
NCT02419131 is a NA study of PTSD and Post-Traumatic Headache that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 193 participants, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02419131, a NA study of PTSD and Post-Traumatic Headache, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- NA
- Development phase
- 193 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall purpose of the study is to compare two talk therapies (Clinic-Based Cognitive Behavioral Therapy and Cognitive Processing Therapy-Cognitive Only) for the treatment of posttraumatic headache (PTHA) and co-morbid posttraumatic stress (PTS). The researchers hope to learn if a non-medication, cognitive-behavioral treatment can result in noticeable reductions in PTHA intensity/severity and frequency as well as PTS symptom severity.
Primary Outcome
Baseline headache-related disability will be assessed over time based on headache-related disability scores on the HIT-6 obtained at multiple time points: at the end of 6 weeks of treatment, and at 3 and 6 months post-treatment. The Headache Impact Test (HIT-6) is a questionnaire for measuring the impact of headache. A total of six questions are completed by the patient. They focus on daily activities such as work, education, home situation and leisure time. The HIT-6 gives a general overview of
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Processing Therapy
- BEHAVIORAL Treatment as Usual
- BEHAVIORAL Behavioral Headache Therapy
Study Locations (1)
Texas
- San Antonio VA Medical Center - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 193 participants |
| Start Date | 2015-05-01 |
| Est. Completion | 2019-10-10 |
| Phase | NA |
What the finished NCT02419131 record still lists
NCT02419131 is an interventional study that assigns participants to a tested intervention. The registered 193 participants enrollment target is mid-sized for trials with a published cap, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (36% lower).
The record links to 2 conditions, with PTSD appearing as the primary indexed condition, and to 3 interventions - of which Cognitive Processing Therapy is the first listed.
NCT02419131 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02419131 about?
NCT02419131 is a clinical study titled "Cognitive-Behavior Therapy for Posttraumatic Headache". The overall purpose of the study is to compare two talk therapies (Clinic-Based Cognitive Behavioral Therapy and Cognitive Processing Therapy-Cognitive Only) for the treatment of posttraumatic headache (PTHA) and co-morbid posttraumatic stress (PTS). The researchers hope to learn if a non-medication...
What is the current status of trial NCT02419131?
This trial is currently completed. It is a NA study. The enrollment target is 193 participants. The study started on 2015-05-01. Estimated completion is 2019-10-10.
What conditions does trial NCT02419131 study?
This clinical trial studies the following conditions: PTSD, Post-Traumatic Headache.
What interventions are being tested in trial NCT02419131?
The interventions under investigation include: Cognitive Processing Therapy (BEHAVIORAL), Treatment as Usual (BEHAVIORAL), Behavioral Headache Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02419131?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02419131 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02419131's enrollment target sits among peer trials
193 30th of 154 higher than 125 of 154 other PTSD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
REstoring Mental Health Through COmmUnity-based Psychological Services in New York City
RECRUITING · NA
-
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06226220 · 193 participants · NA
Percutaneous Nerve Evaluation Trial Time
- NCT03593759 · 194 participants · Phase 3
Cardiac Sarcoidosis Randomized Trial
- NCT05053152 · 194 participants · Phase 2
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
- NCT05156112 · 194 participants · NA
OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI